Risk of COVID-19 Infection After Vaccination

Umeå University2,000,000 enrolled

Overview

The purpose of this observational nationwide study is to evaluate the effects of three different COVID-19 vaccines for the outcome of different severities of incident COVID infection.

Study Type

OBSERVATIONAL

Enrollment

2,000,000

Conditions

Vaccination; Infection Covid19

Interventions

The COVID-19 vaccines BNT162b2, mRNA-1273 and ChAdOx1OTHER

The purpose of the study is to compare the effects of BNT162b2, mRNA-1273 and ChAdOx1 with respect to incident COVID-19 infection of different severities.

Eligibility

Sex: ALLMin age: 0 YearsMax age: 110 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Living in Sweden and vaccinated with BNT162b2, mRNA-1273 or ChAdOx1 * All individuals with a previous COVID-19 infection * Controls matched 1:1 to the groups above Exclusion Criteria: * None

Outcomes

Primary Outcomes

Incident COVID-19 infection

Four different severities: Being diagnosed, hospitalized, ICU-care and death within 30 days of diagnosis

Time frame: Up to six months after vaccination

Central Contacts

Peter Nordström, Prof

CONTACT

+46907851000 peter.nordstrom@umu.se

Marcel Ballin, PhD

CONTACT

marcel.ballin@umu.se

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.